The Just Ask PeterSM Video Guides
We know that learning to use INBRIJA can be a little intimidating, so we created a set of videos to help. With some
practice, we think you'll find INBRIJA to be a real help in your fight against returning PD symptoms.

Hi, I'm Peter!
I'm here to answer your questions about
INBRIJA®. If it's your first time using INBRIJA,
please visit the How to Use INBRIJA page and
watch the demonstration video.

When should I use INBRIJA?
When should I use INBRIJA?
What if I don't hear or feel the whirl when I am using the inhaler?
What if I don't hear or feel the whirl when I am using the inhaler?
What can I do to help with cough when using INBRIJA?
What can I do to help with cough when using INBRIJA?
How fast does INBRIJA start to work?
How fast does INBRIJA start to work?
How should I clean my inhaler?
How should I clean my inhaler?

OFF periods

Show Answers
What is an OFF period or OFF episode?
Does everyone with Parkinson's experience the return of symptoms between regular doses of medication?

About INBRIJA

Show Answers
What are the most common side effects of INBRIJA?
How long does it take for INBRIJA to start to work?
How long will INBRIJA last? How long will it work?
Why doesn't INBRIJA replace my other PD medications?
Does the time I take my oral CD/LD need to be modified depending on when INBRIJA is taken?
Can I use INBRIJA when I have Parkinson's symptoms return as soon as I wake up in the morning?
Are there reasons why I can't take INBRIJA?

Talking with your doctor

Show Answers
What should I tell my doctor before taking INBRIJA?

Using INBRIJA

Show Answers
For information about how to use INBRIJA, including a demonstration video and helpful hints, please see the
How to Use INBRIJA page.
Will I be able to use INBRIJA while I'm experiencing the return of symptoms?
When should I take INBRIJA?
How do I use the INBRIJA inhaler?
Why is one dose in two capsules?
Why can't I swallow the capsules instead of using the inhaler?
How should I inhale INBRIJA?
What if I don't hear or feel the whirl when I am using the inhaler?
What can I do to help with cough when taking INBRIJA?
What can I do to prevent my INBRIJA inhaler from clogging?
What if powder is left in the inhaler or capsule after inhaling a dose?
What if the powder left in my INBRIJA inhaler is dark or discolored?
Why can't I wash the inhaler?
How long can I keep using the same inhaler?

Getting support

Show Answers
What support does Prescription Support Services provide?
Whom can I contact if I have additional questions?
What if I can't afford INBRIJA?

Still have questions?

Call INBRIJA Prescription Support Services

Call toll-free1-888-887-3447
8 AM to 8 PM ET Monday through Friday

Still have questions?

Call INBRIJA Prescription Support Services

Call toll-free1-888-887-3447
8 AM to 8 PM ET Monday through Friday
Indication

INBRIJA is a prescription medicine used when needed for OFF episodes in adults with Parkinson's treated with regular carbidopa/levodopa medicine. INBRIJA does not replace regular carbidopa/levodopa medicine.

Important Safety Information

Do not use INBRIJA if you take or have taken a nonselective monoamine oxidase inhibitor such as phenelzine or tranylcypromine within the last 2 weeks.

Before using INBRIJA, tell your healthcare provider about your medical conditions, including:

  • asthma, chronic obstructive pulmonary disease (COPD), or any chronic lung disease
  • daytime sleepiness, sleep disorders, sleepiness/drowsiness without warning, or use of medicine that increases sleepiness, including antidepressants or antipsychotics
  • dizziness, nausea, sweating, or fainting when standing up
  • abnormal movement (dyskinesia)
  • mental health problems such as hallucinations or psychosis
  • uncontrollable urges like gambling, sexual urges, spending money, or binge eating
  • glaucoma
  • pregnancy or plans to become pregnant. It is unknown if INBRIJA will harm an unborn baby.
  • breastfeeding or plans to breastfeed. Levodopa can pass into breastmilk and it is unknown if it can harm the baby.

Tell your healthcare provider if you take:

  • MAO-B inhibitors
  • dopamine (D2) antagonists (including phenothiazines, butyrophenones, risperidone, metoclopramide)
  • isoniazid
  • iron salts or multivitamins that contain iron salts

Do not drive, operate machinery, or do other activities until you know how INBRIJA affects you. Sleepiness and falling asleep suddenly can happen as late as a year after treatment is started.

Tell your healthcare provider if you experience the following side effects:

  • falling asleep during normal daily activities with or without warning. If you become drowsy, do not drive or do activities where you need to be alert. Chances of falling asleep during normal activities increases if you take medicine that cause sleepiness.
  • withdrawal-emergent hyperpyrexia and confusion (fever, stiff muscles, or changes in breathing and heartbeat) if you suddenly stop using INBRIJA or carbidopa/levodopa, or suddenly lower your dose of carbidopa/levodopa.
  • low blood pressure when standing up (that may be with dizziness, fainting, nausea, and sweating). Get up slowly after sitting/lying down.
  • hallucinations and other psychosis - INBRIJA may cause or worsen seeing/hearing/believing things that are not real; confusion, disorientation, or disorganized thinking; trouble sleeping; dreaming a lot; being overly suspicious or feeling people want to harm you; acting aggressive; and feeling agitated/restless.
  • unusual uncontrollable urges such as gambling, binge eating, shopping, and sexual urges has occurred in some people using medicine like INBRIJA.
  • uncontrolled, sudden body movements (dyskinesia) may be caused or worsened by INBRIJA. INBRIJA may need to be stopped or other Parkinson's medicines may need to be changed.
  • bronchospasm - people with asthma, COPD, or other lung diseases may wheeze or have difficulty breathing after inhaling INBRIJA. If this occurs, stop taking INBRIJA and seek immediate medical attention.
  • increased eye pressure in patients with glaucoma. Your healthcare provider should monitor this.
  • changes in certain lab values including liver tests

The most common side effects of INBRIJA are cough, upper respiratory tract infection, nausea, and change in the color of saliva or spit.

Do not orally inhale more than 1 dose (2 capsules) for any OFF period. Do not take more than 5 doses (10 capsules) in a day.

INBRIJA® Indication

Treats OFF periods in adults taking carbidopa/levodopa (CD/LD). INBRIJA doesn't replace CD/LD.

Important Safety Information

Don't use if you have taken a nonselective monoamine oxidase inhibitor (eg, phenelzine, tranylcypromine) within the last 2 weeks.

SEE MORE see-more